Worrying rise in alcohol related deaths among patients with diabetes

September 08, 2011

Alcohol has become an important cause of death among patients with type 1 diabetes since the 1980s, concludes a study published on bmj.com today.

The study also shows that, while survival of patients with early onset type 1 diabetes (age 0-14 years) has improved with time, survival of patients with late onset type 1 diabetes (age 15-29 years) has deteriorated since the 1980s.

Despite great advances in diabetes care, type 1 diabetes is still associated with premature mortality due to both acute and chronic complications. It is thought that people with late onset diabetes have better long term survival than people with early onset type 1 diabetes, but few studies have compared trends in mortality between early and late onset patients.

So researchers in Finland investigated short and long term time trends in mortality in 17,306 patients diagnosed as having type 1 diabetes below 30 years of age between 1970 and 1999. They also studied the causes of death over time. Participants were followed up for an average of 21 years.

Encouragingly, the researchers found that survival in the early onset group improved from 1970 to 2007. This was explained by a fall in chronic complications of diabetes during the first 20 years of diabetes.

However, this was overshadowed by an increasing trend in both short and long term mortality in the late onset group, due to a rise in alcohol and drug related mortality and acute complications of diabetes.

Alarmingly, mortality due to alcohol and drug related causes accounted for 39% of deaths during the first 20 years of diabetes in this group, say the authors.

They conclude: "This highlights the importance of permanent and long lasting doctor-patient relationships, close supervision, and guidance on the short term and long term effects of alcohol in young people with type 1 diabetes, especially in our alcohol permissive cultures."
-end-


BMJ

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.